Introduction
============

Early and accurate identification of patients with a haematological malignanacy, with a poor outcome on the intensive care, would allow appropriate utilisation of limited resources.

Aim
===

The aim of our study was to evaluate factors that would help predict survivors in-patients with haematological malignancy who required admission to intensive care unit.

Methods
=======

We retrospectively analysed data on patients with haematological malignancy admitted to the intensive care over a 5 year period.

Results
=======

We identified 65 haematological patients, admitted for \>1 day to the intensive care. (Table overleaf.)

  ------------------------- ------------------ ------------------ ---------------- ------------------
                            Survivors          Non-survivors                       
                                                                                   
  Numbers                   Day 1 (*n* = 33)   Day 3 (*n* = 23)   Day 1            Day 3 (*n* = 32)
                                                                                   
  Age (years)               51 (16-76)                            52 (15-74)       
  Sex                       1:2                                   1:2.1            
  APACHE II                 26.5 (11-35)       22 (9-30)          27 (10-44)       26 (14-38)
  Organ failure score       26.3 (11-37.8)     20 (9.2-32.4)      27.6 (10-47.5)   27.3 (14.4-41)
  Number of organ failure   2 (0-3)            1 (0-3)            2 (0-4)          2 (0-4)
  P/F ratio                 187.5 (52-497)     206 (67-543)       190 (48-520)     134 (42-324)
  ------------------------- ------------------ ------------------ ---------------- ------------------

Discussion
==========

There were differences in terms of the demographic data or severity of illness scores on day 1, ie APACHE II and organ failure scores, organ failure days and the P/F ratios between the two groups survivors and non-survivors. However by day 3, there was a significant difference between the survivors and the non-survivors in terms of improvement of the APACHE II and organ failure scores, organ failure days and the P/F ratios.

Conclusion
==========

An improved outcome was associated with an improvement in the day 3 APACHE II and organ failure scores, organ failure days and the P/F ratios, however a failure to do so was associated with a poorer outcome. All survivors could be identified by day 3 of ICU admission.
